Stock Markets July 8, 2026 03:06 PM

Bloom Energy Shares Drop After Short Seller Alleges China-Linked Scandium Reliance

Hunterbrook Capital report challenges Bloom’s public claims of a China-free scandium supply chain; sector funding and market weakness add pressure

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
BE

Bloom Energy Corp shares fell sharply in midday trading after Hunterbrook Capital published a report accusing the company of overstating its independence from Chinese scandium suppliers. The short-seller detailed alleged China-linked trade routes for scandium, disclosed a short position in Bloom, and warned that Bloom’s target to scale to 5 gigawatts of annual production would require nearly the entire projected global supply of scandium oxide. The stock slid from an early session opening around $263 to a low near $235, while broader market softness and a discounted equity offering from a sector peer compounded selling.

Bloom Energy Shares Drop After Short Seller Alleges China-Linked Scandium Reliance
BE
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Hunterbrook Capital published a report titled "Bloom’s Big Lie" alleging Bloom relies on Chinese-linked scandium suppliers despite CEO K.R. Sridhar's statements since early 2025 that the company has "no China supply chain" and is "not dependent on China for scandium."
  • The short-seller identified four China-linked trade routes and cites a confirmation from Hunan Oriental Scandium that it is Bloom’s largest scandium supplier.
  • Hunterbrook contends that Bloom’s aim to scale to 5 gigawatts annually would require roughly 220 tons of scandium oxide, close to a projected global supply of about 240 tons, and disclosed a short position in Bloom shares; market reaction was compounded by a discounted $225 million offering from FuelCell Energy and modest weakness in major indices.

Overview

Bloom Energy Corp shares declined about 7.4% in afternoon trading following publication of a report from short-seller Hunterbrook Capital that questions the company’s public statements about its scandium supply sources. The report, titled "Bloom’s Big Lie," contends that Bloom depends on scandium sourced via China-linked routes, in contrast to repeated remarks from CEO K.R. Sridhar since early 2025 that the company has "no China supply chain" and is "not dependent on China for scandium."


Allegations and evidence cited

Hunterbrook said it used a combination of global trade records, corporate filings, and satellite imagery to identify four separate trade routes tied to China that allegedly supply scandium to Bloom. The short report also states that a representative of Hunan Oriental Scandium confirmed the firm is Bloom’s largest scandium supplier.


Supply-demand concern

Hunterbrook raised a supply constraint argument tied to the metal critical to Bloom’s solid oxide fuel cells. The short-seller calculated that Bloom’s stated objective of scaling to 5 gigawatts of annual production would require roughly 220 tons of scandium oxide. That total is presented as nearly the entire projected global supply of around 240 tons, a gap Hunterbrook says makes Bloom’s growth target appear commercially unattainable on current supply estimates.


Market reaction and company response

The report was accompanied by Hunterbrook disclosing a short position in Bloom Energy shares, a step that added direct selling pressure. Bloom issued a statement saying it is reviewing the report and intends to correct the record, but it had not issued a full rebuttal by the time of afternoon trading.


Sector contagion and broader market context

Sentiment toward Bloom was worsened by a contemporaneous financing event at a sector peer. FuelCell Energy priced a $225 million equity offering at $21 per share, a level characterized in market commentary as a steep discount to its prior trading range. That deal heightened concerns about fundraising conditions in the clean-energy segment and contributed to a sympathetic move against Bloom shares.

Macro conditions provided little offset. The S&P 500 edged down about 0.3% and the Dow Jones fell 1.1% on the same day, reflecting modest risk-off positioning across equities.


Price action and perspective

Bloom shares moved from an early-session open near $263 to a session low of $235.64 after the report surfaced. Despite the intraday weakness, the stock remains substantially above its 52-week low of $24.04 as of the trading session in question.


Summary takeaways

  • The short-seller report challenges Bloom’s public narrative about scandium sourcing and alleges China-linked supply routes.
  • Hunterbrook warned that Bloom’s expansion to 5 gigawatts would demand nearly the entire projected global scandium oxide supply.
  • Bloom said it is reviewing the report and plans to correct the record but had not issued a full rebuttal by afternoon trading; the short-seller disclosed a short position.
  • Market pressure was amplified by a discounted equity offering from a peer and modest weakness in major US equity indices.

Risks

  • Supply concentration risk in critical materials - If the short-seller's supply-chain claims are accurate, Bloom and other clean-energy firms dependent on scandium could face production constraints due to limited global supply; this impacts the clean-energy and materials sectors.
  • Financing risk in the clean-energy sector - The discounted equity offering by FuelCell Energy highlights potential pressures on capital raising for clean-energy firms, which could affect company growth plans and valuations in the sector.
  • Reputational and regulatory risk - Allegations by a short-seller and the associated market impact could force increased scrutiny, require corrective disclosures, or delay strategic plans if Bloom must address supply-chain questions publicly.

More from Stock Markets

Paradigm Raises $1.2 Billion Fourth Fund as It Moves Beyond Crypto Into AI and Robotics Jul 8, 2026 JPMorgan Assembles Dedicated Team to Pursue Small-Cap M&A Opportunities Jul 8, 2026 U.S. SEC Clears Legal Path for UBS’ Potential Bail-In Actions Jul 8, 2026 NVIDIA Shares Bounce After Company Rebuts Reported Delay in Kyber AI Rack Jul 8, 2026 Alignment Healthcare Shares Plummet After Whistleblower Alleges Accounting Manipulation Jul 8, 2026